BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32704083)

  • 1. An approach to classifying occupational exposures to endocrine disrupting chemicals by sex hormone function using an expert judgment process.
    Prichystalova R; Caron-Beaudoin E; Richardson L; Dirkx E; Amadou A; Zavodna T; Cihak R; Cogliano V; Hynes J; Pelland-St-Pierre L; Verner MA; van Tongeren M; Ho V
    J Expo Sci Environ Epidemiol; 2021 Jul; 31(4):753-768. PubMed ID: 32704083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the estrogenic and androgenic properties of tetra- and hexachloronaphthalene by YES/YAS in vitro assays.
    Stragierowicz J; Stypuła-Trębas S; Radko L; Posyniak A; Nasiadek M; Klimczak M; Kilanowicz A
    Chemosphere; 2021 Jan; 263():128006. PubMed ID: 33297039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of endocrine-disrupting activities of alternative chemicals for bis(2-ethylhexyl)phthalate.
    Park J; Park C; Gye MC; Lee Y
    Environ Res; 2019 May; 172():10-17. PubMed ID: 30769184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro estrogenic activity of representative endocrine disrupting chemicals mixtures at environmentally relevant concentrations.
    Yu H; Caldwell DJ; Suri RP
    Chemosphere; 2019 Jan; 215():396-403. PubMed ID: 30336316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of estrogenic compounds in paperboard for dry food packaging with the ERE-CALUX bioassay.
    Vandermarken T; Boonen I; Gryspeirt C; Croes K; Van Den Houwe K; Denison MS; Gao Y; Van Hoeck E; Elskens M
    Chemosphere; 2019 Apr; 221():99-106. PubMed ID: 30634153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in urinary excretion of phthalates, phthalate substitutes, bisphenols and other polychlorinated and phenolic substances in young Danish men; 2009-2017.
    Frederiksen H; Nielsen O; Koch HM; Skakkebaek NE; Juul A; Jørgensen N; Andersson AM
    Int J Hyg Environ Health; 2020 Jan; 223(1):93-105. PubMed ID: 31669154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenic activity, chemical levels and health risk assessment of municipal distribution point water from Pretoria and Cape Town, South Africa.
    Van Zijl MC; Aneck-Hahn NH; Swart P; Hayward S; Genthe B; De Jager C
    Chemosphere; 2017 Nov; 186():305-313. PubMed ID: 28787686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental exposures to endocrine disrupting chemicals (EDCs) and their role in endometriosis: a systematic literature review.
    Sirohi D; Al Ramadhani R; Knibbs LD
    Rev Environ Health; 2021 Mar; 36(1):101-115. PubMed ID: 32903210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
    Yilmaz B; Terekeci H; Sandal S; Kelestimur F
    Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to endocrine disruptors during adulthood: consequences for female fertility.
    Rattan S; Zhou C; Chiang C; Mahalingam S; Brehm E; Flaws JA
    J Endocrinol; 2017 Jun; 233(3):R109-R129. PubMed ID: 28356401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression patterns in developing sexually dimorphic rat brain regions exposed to antiandrogenic, estrogenic, or complex endocrine disruptor mixtures: glutamatergic synapses as target.
    Lichtensteiger W; Bassetti-Gaille C; Faass O; Axelstad M; Boberg J; Christiansen S; Rehrauer H; Georgijevic JK; Hass U; Kortenkamp A; Schlumpf M
    Endocrinology; 2015 Apr; 156(4):1477-93. PubMed ID: 25607892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of endocrine disrupting phthalates and hormonal alterations in children and adolescents.
    Hyun Kim D; Min Choi S; Soo Lim D; Roh T; Jun Kwack S; Yoon S; Kook Kim M; Sil Yoon K; Sik Kim H; Wook Kim D; Lee BM
    J Toxicol Environ Health A; 2018; 81(21):1150-1164. PubMed ID: 30415604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt pathway: A mechanism worth considering in endocrine disrupting chemical action.
    Üstündağ ÜV; Emekli-Alturfan E
    Toxicol Ind Health; 2020 Jan; 36(1):41-53. PubMed ID: 31914870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle.
    Dickerson SM; Gore AC
    Rev Endocr Metab Disord; 2007 Jun; 8(2):143-59. PubMed ID: 17674209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Endocrine Disruption Activity of Deposits on Firefighting Gear Using a Sensitive and High Throughput Screening Method.
    Stevenson M; Alexander B; Baxter CS; Leung YK
    J Occup Environ Med; 2015 Dec; 57(12):e153-7. PubMed ID: 26641839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Human Estrogen Receptor Dimerization Assay for the Estrogenic Endocrine-Disrupting Chemicals Using Bioluminescence Resonance Energy Transfer.
    Kim HM; Seo H; Park Y; Lee HS; Lee SH; Ko KS
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p,p'-Dichlordiphenyldichloroethylene (p,p'-DDE) can elicit antiandrogenic and estrogenic modes of action in the amphibian Xenopus laevis.
    Hoffmann F; Kloas W
    Physiol Behav; 2016 Dec; 167():172-178. PubMed ID: 27640133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone receptor (lhcgr) as a marker gene for characterizing estrogenic endocrine-disrupting chemicals in zebrafish ovarian follicle cells.
    Liu KC; Wu RS; Ge W
    Gen Comp Endocrinol; 2013 Oct; 192():89-94. PubMed ID: 23851042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine disrupting chemicals and bone.
    Turan S
    Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101495. PubMed ID: 33618984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study.
    Long M; Ghisari M; Kjeldsen L; Wielsøe M; Nørgaard-Pedersen B; Mortensen EL; Abdallah MW; Bonefeld-Jørgensen EC
    Mol Autism; 2019; 10():1. PubMed ID: 30647876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.